These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1147 related items for PubMed ID: 22956068

  • 21. Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?
    Truong PT, Sadek BT, Lesperance MF, Alexander CS, Shenouda M, Raad RA, Taghian AG.
    Int J Radiat Oncol Biol Phys; 2014 Jan 01; 88(1):57-64. PubMed ID: 24161421
    [Abstract] [Full Text] [Related]

  • 22. Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgery.
    Biglia N, Ponzone R, Bounous VE, Mariani LL, Maggiorotto F, Benevelli C, Liberale V, Ottino MC, Sismondi P.
    Breast; 2014 Dec 01; 23(6):870-5. PubMed ID: 25305040
    [Abstract] [Full Text] [Related]

  • 23. Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation.
    Panoff JE, Hurley J, Takita C, Reis IM, Zhao W, Sujoy V, Gomez CR, Jorda M, Koniaris L, Wright JL.
    Breast Cancer Res Treat; 2011 Aug 01; 128(3):899-906. PubMed ID: 21475999
    [Abstract] [Full Text] [Related]

  • 24. HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy.
    Jia H, Jia W, Yang Y, Li S, Feng H, Liu J, Rao N, Jin L, Wu J, Gu R, Zhu L, Chen K, Deng H, Zeng Y, Liu Q, Song E, Su F.
    World J Surg Oncol; 2014 Sep 20; 12():289. PubMed ID: 25241216
    [Abstract] [Full Text] [Related]

  • 25. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1514-21. PubMed ID: 16005576
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.
    Jpn J Clin Oncol; 2005 Mar 01; 35(3):126-33. PubMed ID: 15741302
    [Abstract] [Full Text] [Related]

  • 28. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y, Guan Y, Zhao WH, Li Q, Xu BH.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec 01; 30(12):917-20. PubMed ID: 19173993
    [Abstract] [Full Text] [Related]

  • 29. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT, Jones SO, Kader HA, Wai ES, Speers CH, Alexander AS, Olivotto IA.
    Int J Radiat Oncol Biol Phys; 2009 Feb 01; 73(2):357-64. PubMed ID: 18676091
    [Abstract] [Full Text] [Related]

  • 30. Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile?
    Ugras S, Matsen C, Eaton A, Stempel M, Morrow M, Cody HS.
    Ann Surg Oncol; 2016 Mar 01; 23(3):744-8. PubMed ID: 26644258
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Triple-negative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy.
    Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.
    Int J Radiat Oncol Biol Phys; 2011 Jul 15; 80(4):1095-101. PubMed ID: 20638197
    [Abstract] [Full Text] [Related]

  • 36. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J, Mózsa E, Zaka Z, Polgár C, Major T.
    Magy Onkol; 2005 Jul 15; 49(3):203, 205-8. PubMed ID: 16249814
    [Abstract] [Full Text] [Related]

  • 37. Is conservative surgery a good option for patients with "triple negative" breast cancer?
    Martinez-Ramos D, Escrig-Sos J, Torrella-Ramos A, Alcalde-Sanchez M, Salvador-Sanchis JL.
    Breast; 2012 Jun 15; 21(3):401-5. PubMed ID: 22579462
    [Abstract] [Full Text] [Related]

  • 38. [The clinical research of local recurrence after breast-conserving therapy for breast cancer].
    Wang LZ, Ouyang T, Wang TF, Xie YT, Fan ZQ, Fan T, Lin BY, Li JF.
    Zhonghua Wai Ke Za Zhi; 2010 Dec 15; 48(24):1851-4. PubMed ID: 21211266
    [Abstract] [Full Text] [Related]

  • 39. Breast-conserving therapy in breast cancer patients--a 12-year experience.
    Mannell A.
    S Afr J Surg; 2005 May 15; 43(2):28-30; discussion 30, 32. PubMed ID: 16035379
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.